Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia

    October 2022 in “ The Journal of Clinical Pharmacology ”
    Robert Krysiak, Marcin Basiak, Witold Szkróbka, Bogusław Okopień
    Studysummary This study found that men with early-onset androgenic alopecia are less responsive to the cardiometabolic effects of bromocriptine compared to men with normal hair growth.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Impaired Metabolic Effects of Metformin in Men with Early-Onset Androgenic Alopecia Pharmacological Reports · 2021
    2. Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia Molecules · 2021
    3. Alopecia and the Metabolic Syndrome Clinics in Dermatology · 2017
    4. Does a Male Polycystic Ovarian Syndrome Equivalent Exist? Journal of Endocrinological Investigation · 2017
    5. Polycystic Ovary Syndrome in Men Medical Hypotheses · 2017
    6. Androgenetic Alopecia: A Review Endocrine · 2017
    7. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women JAMA Dermatology · 2016
    8. Androgenetic Alopecia: An Update Indian Journal of Dermatology, Venereology and Leprology · 2013